Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 352

Similar articles for PubMed (Select 21120644)

1.

Modified cyclophosphamide, vincristine, doxorubicin, and methotrexate (CODOX-M)/ifosfamide, etoposide, and cytarabine (IVAC) therapy with or without rituximab in Japanese adult patients with Burkitt lymphoma (BL) and B cell lymphoma, unclassifiable, with features intermediate between diffuse large B cell lymphoma and BL.

Maruyama D, Watanabe T, Maeshima AM, Nomoto J, Taniguchi H, Azuma T, Mori M, Munakata W, Kim SW, Kobayashi Y, Matsuno Y, Tobinai K.

Int J Hematol. 2010 Dec;92(5):732-43. doi: 10.1007/s12185-010-0728-0. Epub 2010 Dec 1.

PMID:
21120644
2.

Lymphomatoid Granulomatosis with Central Nervous System Involvement Successfully Treated with Cyclophosphamide, High-dose Cytarabine, Dexamethasone, Etoposide, and Rituximab (CHASER therapy) Followed by Brain Irradiation: A Case Study.

Fujimaki M, Kawajiri S, Ichikawa K, Tomizawa Y, Nakazato T, Noda K, Hattori N, Koike M, Okuma Y.

CNS Neurosci Ther. 2015 Jul;21(7):610-2. doi: 10.1111/cns.12414. No abstract available.

PMID:
26096049
3.

[B-cell lymphoma, unclassifiable, intermediate between diffuse large B-cell lymphoma and Burkitt's lymphoma].

Baryakh EA, Misyurina AE, Kovrigina AM, Misyurin VA, Kravchenko SK.

Ter Arkh. 2015;87(4):91-7. Russian.

PMID:
26087641
4.

Outcome is unchanged by adding vincristine upfront to the Malawi 28-day protocol for endemic Burkitt lymphoma.

Depani S, Banda K, Bailey S, Israels T, Chagaluka G, Molyneux E.

Pediatr Blood Cancer. 2015 Jun 5. doi: 10.1002/pbc.25612. [Epub ahead of print]

PMID:
26052841
5.

Bilateral subdural hygromas following administration of intrathecal methotrexate chemotherapy.

Lewis H, Mahdi AJ, Rowntree C.

BMJ Case Rep. 2015 May 22;2015. pii: bcr2014205059. doi: 10.1136/bcr-2014-205059.

PMID:
26002663
6.

[Pathology of the mediastinum. Case 2. B cell unclassifiable lymphoma with intermediate features between classic Hodgkin lymphoma and primary large B cell lymphoma].

Traverse-Glehen A.

Ann Pathol. 2015 Jun;35(3):218-23. doi: 10.1016/j.annpat.2015.03.006. Epub 2015 May 20. French. No abstract available.

PMID:
26001355
7.

Efficacy of Two Cleaning Solutions for the Decontamination of 10 Antineoplastic Agents in the Biosafety Cabinets of a Hospital Pharmacy.

Anastasi M, Rudaz S, Queruau Lamerie T, Odou P, Bonnabry P, Fleury-Souverain S.

Ann Occup Hyg. 2015 May 15. pii: mev031. [Epub ahead of print]

PMID:
25979920
8.

AMC 048: modified CODOX-M/IVAC-rituximab is safe and effective for HIV-associated Burkitt lymphoma.

Noy A, Lee JY, Cesarman E, Ambinder R, Baiocchi R, Reid E, Ratner L, Wagner-Johnston N, Kaplan L.

Blood. 2015 May 8. pii: blood-2015-01-623900. [Epub ahead of print]

PMID:
25957391
9.

[Unclassifiable B-cell lymphoma: Between diffuse large B-cell lymphoma and Burkitt lymphoma].

Mahdi Y, Malihy A, Kettani F, Alaammari I, Khmou M, Touri S, Rouas L, Lamalmi N, El Khorassani M, Alhamany Z.

Arch Pediatr. 2015 Jun;22(6):661-4. doi: 10.1016/j.arcped.2015.03.019. Epub 2015 Apr 28. French. No abstract available.

PMID:
25934611
10.

Front-line, dose-escalated immunochemotherapy is associated with a significant progression-free survival advantage in patients with double-hit lymphomas: a systematic review and meta-analysis.

Howlett C, Snedecor SJ, Landsburg DJ, Svoboda J, Chong EA, Schuster SJ, Nasta SD, Feldman T, Rago A, Walsh KM, Weber S, Goy A, Mato A.

Br J Haematol. 2015 Apr 24. doi: 10.1111/bjh.13463. [Epub ahead of print]

PMID:
25907897
11.

Predictors of local recurrence after rituximab-based chemotherapy alone in stage III and IV diffuse large B-cell lymphoma: guiding decisions for consolidative radiation.

Jegadeesh N, Rajpara R, Esiashvili N, Shi Z, Liu Y, Okwan-Duodu D, Flowers CR, Khan MK.

Int J Radiat Oncol Biol Phys. 2015 May 1;92(1):107-12. doi: 10.1016/j.ijrobp.2015.01.025.

PMID:
25863758
12.

Burkitt leukaemia/lymphoma: R-CODOX-M/R-IVAC remains gold standard treatment in BL.

Smyth L, Browne PV, Conneally E, Flynn C, Hayden P, Jeffers M, O'Brien D, Quinn F, Kelly J, Perera M, Crotty GM, Leahy M, Hennessy B, Jackson F, Ryan M, Vandenberghe E.

Ir J Med Sci. 2015 Apr 7. [Epub ahead of print]

PMID:
25843016
13.

Adding rituximab to CODOX-M/IVAC chemotherapy in the treatment of HIV-associated Burkitt lymphoma is safe when used with concurrent combination antiretroviral therapy.

Alwan F, He A, Montoto S, Kassam S, Mee M, Burns F, Edwards S, Wilson A, Tenant-Flowers M, Marcus R, Ardeshna KM, Bower M, Cwynarski K.

AIDS. 2015 May 15;29(8):903-10. doi: 10.1097/QAD.0000000000000623.

PMID:
25730506
14.

Pediatric B-cell lymphoma, unclassifiable, with intermediate features between those of diffuse large B-cell lymphoma and Burkitt lymphoma: a report of two cases.

Zhang S, Wilson D, Czader M.

Ann Lab Med. 2015 Mar;35(2):254-6. doi: 10.3343/alm.2015.35.2.254. Epub 2015 Feb 12. No abstract available.

15.

miR expression in MYC-negative DLBCL/BL with partial trisomy 11 is similar to classical Burkitt lymphoma and different from diffuse large B-cell lymphoma.

Zajdel M, Rymkiewicz G, Chechlinska M, Blachnio K, Pienkowska-Grela B, Grygalewicz B, Goryca K, Cieslikowska M, Bystydzienski Z, Swoboda P, Walewski J, Siwicki JK.

Tumour Biol. 2015 Feb 13. [Epub ahead of print]

PMID:
25677902
16.

Outcome of Patients With Non-Hodgkin Lymphomas With Concurrent MYC and BCL2 Rearrangements Treated With CODOX-M/IVAC With Rituximab Followed by Hematopoietic Stem Cell Transplantation.

Sun H, Savage KJ, Karsan A, Slack GW, Gascoyne RD, Toze CL, Sehn LH, Abou Mourad Y, Barnett MJ, Broady RC, Connors JM, Forrest DL, Gerrie AS, Hogge DE, Narayanan S, Nevill TJ, Nantel SH, Power MM, Sutherland HJ, Villa D, Shepherd JD, Song KW.

Clin Lymphoma Myeloma Leuk. 2015 Jun;15(6):341-8. doi: 10.1016/j.clml.2014.12.015. Epub 2015 Jan 3.

PMID:
25656914
17.
18.

[A case of primary mediastinal (Thymic) B-cell lymphoma successfully treated with the DA-EPOCH-R Regimen].

Higashide Y, Hayashi T, Hirayama D, Wagatsuma K, Aoki Y, Maruyama Y, Ikeda H, Ishida T, Shinomura Y.

Gan To Kagaku Ryoho. 2015 Jan;42(1):119-22. Japanese.

PMID:
25596693
19.

A pilot study of the safety and efficacy of dexamethasone, ifosfamide, methotrexate and gemcitabine chemotherapy for natural killer/T-cell lymphoma.

Yang J, Shi Y, He X, Dong M, Zhang C, Liu P, Zhou S, Qin Y, Gui L, Yang S, Sun Y.

Leuk Lymphoma. 2015 Feb 11:1-4. [Epub ahead of print] No abstract available.

PMID:
25563558
20.

A case of clonally distinct relapse of Burkitt lymphoma 9 years after complete remission.

Kojima M, Nakamura N, Yabe M, Tokunaka M, Kikuti YY, Kikuchi T, Murayama H, Moriuchi M, Tsuboi K, Ogawa Y, Ando K.

Int J Hematol. 2015 May;101(5):520-4. doi: 10.1007/s12185-014-1729-1. Epub 2015 Jan 3.

PMID:
25555480
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk